Richard E. Chaisson
Affiliations: | Johns Hopkins University, Baltimore, MD |
Area:
Epidemiology, Public HealthGoogle:
"Richard Chaisson"Cross-listing: Epi Tree
Children
Sign in to add traineeDiana S. Pope | grad student | 2007 | Johns Hopkins |
Kelly E. Dooley | grad student | 2009 | Johns Hopkins (Epi Tree) |
Shama D. Ahuja | grad student | 2010 | Johns Hopkins |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gupta A, Hughes MD, Cruz JL, et al. (2023) Adverse Pregnancy Outcomes among HIV-infected Women Taking Isoniazid Preventive Therapy During the First Trimester. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
Reid M, Agbassi YJP, Arinaminpathy N, et al. (2023) Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis. Lancet (London, England) |
Malhotra A, Nonyane BAS, Shirey E, et al. (2023) Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB). Trials. 24: 475 |
Ryckman T, Weiser J, Gombe M, et al. (2023) Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis. The Lancet. Global Health. 11: e1205-e1216 |
Jarrett RT, van der Heijden Y, Shotwell MS, et al. (2023) High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus. Antimicrobial Agents and Chemotherapy. e0129722 |
Pettit AC, Phillips PP, Kurbatova E, et al. (2022) Rifapentine with and without moxifloxacin for pulmonary tuberculosis in people with HIV (S31/A5349). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
Singh P, Moulton LH, Barnes GL, et al. (2022) Pregnancy in Women with HIV in a Tuberculosis Preventive Therapy Trial. Journal of Acquired Immune Deficiency Syndromes (1999) |
Podany AT, Pham M, Sizemore E, et al. (2021) Efavirenz pharmacokinetics and HIV-1 viral suppression among patients receiving TB treatment containing daily high-dose rifapentine. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
Churchyard G, Cárdenas V, Chihota V, et al. (2021) Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial. Annals of Internal Medicine |
Chaisson LH, Saraceni V, Cohn S, et al. (2021) Yield of repeat tuberculin skin testing for people living with HIV in Brazil. Journal of Acquired Immune Deficiency Syndromes (1999) |